Cosmax, Inc. (KRX:192820)

Market Cap	2.80T +20.2%
Revenue (ttm)	2.66T +15.8%
Net Income	184.27B +197.3%
EPS	16,241.80 +197.3%
Shares Out	11.35M
PE Ratio	15.21
Forward PE	17.08
Dividend	3,300.00 (1.34%)
Ex-Dividend Date	Mar 30, 2026

Volume	124,921
Open	247,000
Previous Close	248,000
Day's Range	241,500 - 256,000
52-Week Range	141,000 - 320,000
Beta	0.80
Analysts	Buy
Price Target	316,840.00 (+28.28%)
Est. Earnings	Nov 11, 2026

About Cosmax

Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1992
• Employees: 1,645
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 192820

Financial Performance

In 2025, Cosmax's revenue was 2.40 trillion, an increase of 10.74% compared to the previous year's 2.17 trillion. Earnings were 123.06 billion, an increase of 43.44%.

Analyst Summary

According to 25 analysts, the average rating for 192820 stock is "Buy." The 12-month stock price target is ₩316,840, which is an increase of 28.28% from the latest price.

Price Target

₩316,840

(28.28% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error